Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5186603
Max Phase: Preclinical
Molecular Formula: C147H215N39O34
Molecular Weight: 3072.58
Associated Items:
ID: ALA5186603
Max Phase: Preclinical
Molecular Formula: C147H215N39O34
Molecular Weight: 3072.58
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)N1C(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CC(C)C)Cc2ccccc21)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)O
Standard InChI: InChI=1S/C147H215N39O34/c1-83(2)71-92(152)124(197)176-105(74-86-31-10-6-11-32-86)137(210)180-108(78-90-79-160-82-164-90)138(211)179-107(76-88-46-48-91(187)49-47-88)136(209)171-97(51-57-117(154)189)129(202)170-96(50-56-116(153)188)128(201)168-95(38-18-22-64-150)127(200)169-98(52-58-118(155)190)130(203)174-101(39-19-23-65-151)141(214)183-68-26-43-113(183)144(217)182-67-25-42-111(182)139(212)163-81-122(194)166-104(73-85-29-8-5-9-30-85)134(207)167-93(36-16-20-62-148)125(198)162-80-121(193)165-94(37-17-21-63-149)126(199)181-109-77-89-35-14-15-41-110(89)186(143(109)216)112(55-60-120(157)192)140(213)173-99(53-59-119(156)191)131(204)178-106(75-87-33-12-7-13-34-87)135(208)172-100(54-61-123(195)196)132(205)177-103(72-84(3)4)133(206)175-102(40-24-66-161-147(158)159)142(215)184-69-27-44-114(184)145(218)185-70-28-45-115(185)146(219)220/h5-15,29-35,41,46-49,79,82-84,92-109,111-115,187H,16-28,36-40,42-45,50-78,80-81,148-152H2,1-4H3,(H2,153,188)(H2,154,189)(H2,155,190)(H2,156,191)(H2,157,192)(H,160,164)(H,162,198)(H,163,212)(H,165,193)(H,166,194)(H,167,207)(H,168,201)(H,169,200)(H,170,202)(H,171,209)(H,172,208)(H,173,213)(H,174,203)(H,175,206)(H,176,197)(H,177,205)(H,178,204)(H,179,211)(H,180,210)(H,181,199)(H,195,196)(H,219,220)(H4,158,159,161)/t92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,111-,112-,113-,114-,115-/m0/s1
Standard InChI Key: ZUMNRPNLIQHEKU-PSSZCNAGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 3072.58 | Molecular Weight (Monoisotopic): 3070.6294 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Reynaud S, Laurin SA, Ciolek J, Barbe P, Van Baelen AC, Susset M, Blondel F, Ghazarian M, Boeri J, Vanden Driessche M, Upert G, Mourier G, Kessler P, Konnert L, Beroud R, Keck M, Servent D, Bouvier M, Gilles N.. (2022) From a Cone Snail Toxin to a Competitive MC4R Antagonist., 65 (18.0): [PMID:36063022] [10.1021/acs.jmedchem.2c00786] |
Source(1):